These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1615584)

  • 1. Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?
    Teppema JS; de Boer EC; Steerenberg PA; van der Meijden AP
    Urol Res; 1992; 20(3):219-28. PubMed ID: 1615584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.
    Balemans LT; Vegt PD; Steerenberg PA; De Boer EC; Van Swaaij A; De Vries RE; Van der Meijden AP; Den Otter W
    Urol Res; 1994; 22(4):239-45. PubMed ID: 7871637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro.
    Schneider B; Thanhäuser A; Jocham D; Loppnow H; Vollmer E; Galle J; Flad HD; Ulmer AJ; Böhle A
    World J Urol; 1994; 12(6):337-44. PubMed ID: 7881473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG).
    de Reijke TM; Vos PC; de Boer EC; Bevers RF; de Muinck Keizer WH; Kurth KH; Schamhart DH
    Urol Res; 1993; 21(5):349-52. PubMed ID: 8279092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans.
    Mitropoulos D; Petsis D; Kyroudi-Voulgari A; Kouloukoussa M; Zervas A; Dimopoulos C
    Nitric Oxide; 2005 Aug; 13(1):36-41. PubMed ID: 15964223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical BCG administration in the guinea pig. II. Immunohistochemical characterization of cellular infiltrate after one or two cycles of intravesical BCG.
    de Jong WH; De Boer EC; Van Der Meijden AP; Steerenberg PA; Debruyne FM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(3):159-67. PubMed ID: 1685277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
    Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
    J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different Bacillus Calmette-Guerin substrains on growth inhibition of T24 bladder cancer cells and cytokines secretion by BCG activated peripheral blood mononuclear cells of PBMCs.
    Janaszek-Seydlitz W; Prygiel M; Bucholc B; Wiatrzyk A; Czajka U; Górska P; Soliwoda U
    Adv Clin Exp Med; 2014; 23(6):877-84. PubMed ID: 25618112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review.
    Patard JJ; Saint F; Velotti F; Abbou CC; Chopin DK
    Urol Res; 1998; 26(3):155-9. PubMed ID: 9694595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig.
    de Boer EC; Steerenberg PA; van der Meijden AP; van Klingeren B; de Jong WH; Debruyne FM; Ruitenberg EJ
    Prog Clin Biol Res; 1992; 378():81-93. PubMed ID: 1301589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response.
    De Boer EC; Rooijakkers SJ; Schamhart DH; Kurth KH
    J Urol; 2003 Nov; 170(5):2004-8. PubMed ID: 14532842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.
    Ratliff TL; Kavoussi LR; Catalona WJ
    J Urol; 1988 Feb; 139(2):410-4. PubMed ID: 3276931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.
    Kavoussi LR; Brown EJ; Ritchey JK; Ratliff TL
    J Clin Invest; 1990 Jan; 85(1):62-7. PubMed ID: 2404029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterial adherence and BCG treatment of superficial bladder cancer.
    Schamhart DH; de Boer EC; Bevers RF; Kurth KH; Steerenberg PA
    Prog Clin Biol Res; 1992; 378():75-80. PubMed ID: 1284504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.
    Hudson MA; Brown EJ; Ritchey JK; Ratliff TL
    Cancer Res; 1991 Jul; 51(14):3726-32. PubMed ID: 2065329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between bacteria and the lumenal bladder surface: modulation by pentosan polysulfate, an experimental and theoretical approach with clinical implication.
    Schamhart DH; de Boer EC; Kurth KH
    World J Urol; 1994; 12(1):27-37. PubMed ID: 7516779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization of bacille Calmette-Guerin by bladder tumor cells.
    Becich MJ; Carroll S; Ratliff TL
    J Urol; 1991 Jun; 145(6):1316-24. PubMed ID: 2033723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment.
    Saint F; Patard JJ; Groux Muscatelli B; Lefrere Belda MA; Gil Diez de Medina S; Abbou CC; Chopin DK
    BJU Int; 2001 Oct; 88(6):602-10. PubMed ID: 11678759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer.
    Bevers RF; Kurth KH; Schamhart DH
    Br J Cancer; 2004 Aug; 91(4):607-12. PubMed ID: 15266312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.